These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results

Benzinga

07/24

Tenet Healthcare Corporation (NYSE:THC) posted better-than-expected earnings for the second quarter on Tuesday.

The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.

The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.

“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”

Tenet Healthcare shares rose 1% to trade at $157.49 on Wednesday.

These analysts made changes to their price targets on Tenet Healthcare following earnings announcement.

Guggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.
Raymond James analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.

Considering buying THC stock? Here’s what analysts think:

Read This Next:

Wall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2553019244"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553019244\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553019244?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-24 01:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553019244","market":"us","top_or_hot":-1,"title":"These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results","media":"Benzinga","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/THC\">Tenet Healthcare</a> Corporation</strong> (<a href=\"https://laohu8.com/S/NYSE\">NYSE</a>:THC) posted better-than-expected earnings for the second quarter on Tuesday.</p>\n<p>The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.</p>\n<p>The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.</p>\n<p>“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”</p>\n<p>Tenet <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> shares rose 1% to trade at $157.49 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Tenet Healthcare following earnings announcement.</p>\n<ul>\n<li>Guggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.</li>\n<li><a href=\"https://laohu8.com/S/RJF\">Raymond James</a> analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.</li>\n</ul>\n<p><strong>Considering buying THC stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"551\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341.png 1098w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Wall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields</strong></li>\n</ul>\n<p>Photo via <a href=\"https://laohu8.com/S/SSTK\">Shutterstock</a></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Boost Their Forecasts On Tenet Healthcare After Upbeat Q2 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-07-24 01:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/THC\">Tenet Healthcare</a> Corporation</strong> (<a href=\"https://laohu8.com/S/NYSE\">NYSE</a>:THC) posted better-than-expected earnings for the second quarter on Tuesday.</p>\n<p>The company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.</p>\n<p>The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.</p>\n<p>“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”</p>\n<p>Tenet <a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> shares rose 1% to trade at $157.49 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Tenet Healthcare following earnings announcement.</p>\n<ul>\n<li>Guggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.</li>\n<li><a href=\"https://laohu8.com/S/RJF\">Raymond James</a> analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.</li>\n</ul>\n<p><strong>Considering buying THC stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"551\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/23132231/image-341.png 1098w\" width=\"1024\"/></figure>\n<p><strong>Read This Next: </strong></p>\n<ul>\n<li><strong>Wall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields</strong></li>\n</ul>\n<p>Photo via <a href=\"https://laohu8.com/S/SSTK\">Shutterstock</a></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861165.SGD","symbol_name":"Natixis Harris Associates Global Equity PA SGD","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46581222/these-analysts-boost-their-forecasts-on-tenet-healthcare-after-upbeat-q2-results","article_id":"2553019244","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553019244","pubTimestamp":1753291449,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","BK4185":"保健护理机构","THC":"泰尼特","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU0963586101.USD":"ALLIANZ GLOBAL SMALL CAP EQUITY \"AT\" ACC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC"},"translate_title":"在第二季度业绩乐观后，这些分析师上调了对Tenet Healthcare的预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"THC":1},"content_text":"Tenet Healthcare Corporation (NYSE:THC) posted better-than-expected earnings for the second quarter on Tuesday.\nThe company reported quarterly earnings of $4.02 per share which beat the analyst consensus estimate of $2.87 per share. The company reported quarterly sales of $5.271 billion which beat the analyst consensus estimate of $5.161 billion.\nThe company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance from $20.600 billion-$21.000 billion to $20.950 billion-$21.250 billion.\n“Our strong second quarter results extend our track record of attractive same store revenue growth, operational performance driven by fundamentals, and robust free cash flow generation,” said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. “We continue to make investments both organically and inorganically to expand our capabilities and innovate to better serve our patients.”\nTenet Healthcare shares rose 1% to trade at $157.49 on Wednesday.\nThese analysts made changes to their price targets on Tenet Healthcare following earnings announcement.\n\nGuggenheim analyst Jason Cassorla maintained Tenet Healthcare with a Buy and raised the price target from $180 to $188.\nRaymond James analyst John Ransom reiterated the stock with an Outperform rating and raised the price target from $185 to $200.\n\nConsidering buying THC stock? Here’s what analysts think: \n\nRead This Next: \n\nWall Street’s Most Accurate Analysts Weigh In On 3 Industrials Stocks With Over 5% Dividend Yields\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}